PIOLAX (5988) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
12 May, 2026Executive summary
Net sales declined 2.1% year-over-year to ¥62,045 million for the fiscal year ended March 31, 2026.
Operating profit dropped 38.3% year-over-year to ¥1,470 million, and ordinary profit fell 57.3% to ¥1,453 million.
Profit attributable to owners of parent was a loss of ¥21 million, compared to a profit of ¥1,792 million the previous year.
Comprehensive income decreased sharply to ¥1,198 million from ¥5,037 million year-over-year.
Financial highlights
Gross profit was ¥13,728 million, down from ¥14,271 million year-over-year.
Cash flows from operating activities decreased to ¥3,003 million from ¥8,124 million year-over-year.
Cash and cash equivalents at year-end were ¥22,773 million, down from ¥30,236 million.
Equity-to-asset ratio declined to 63.9% from 85.8% year-over-year.
Outlook and guidance
For the fiscal year ending March 31, 2027, net sales are forecast at ¥63,000 million (+1.5% YoY), operating profit at ¥1,500 million (+2.0%), and profit attributable to owners of parent at ¥700 million.
Latest events from PIOLAX
- Sales up 3.2% but profits down; focus on CASE, global growth, and capital returns.5988
Q2 202516 Mar 2026 - Profits and sales fell sharply, but long-term growth targets and strong shareholder returns remain.5988
Q4 202516 Mar 2026 - Sales rose but profits fell on higher costs; full-year profit forecast remains lower.5988
Q1 202516 Mar 2026 - Net income fell 52% year-over-year as sales and profitability declined, with guidance unchanged.5988
Q3 202516 Mar 2026 - Profits and sales fell sharply, prompting strategic focus on innovation and cost control.5988
Q2 202616 Mar 2026 - Profits and comprehensive income fell sharply, with a cautious outlook for the full year.5988
Q1 202616 Mar 2026 - Profits and comprehensive income fell sharply, but a moderate recovery is forecasted.5988
Q3 202616 Mar 2026